Monday, August 31, 2020

Nestle to buy Aimmune Therapeutics, valuing allergy treatment maker at $2.6 billion

Nestle to buy Aimmune Therapeutics, valuing allergy treatment maker at $2.6 billion The offer values the California-based biopharmaceutical company at $2.6 billion, including the $473 million that Nestle had already invested in Aimmune, Nestle said in a statement.

from Moneycontrol Business News https://ift.tt/2QEFiGF

No comments:

Post a Comment

Asian shares start cautiously, dollar edges down

Asian shares opened cautiously amid anticipation of fresh trade news influencing US asset demand. The dollar weakened as trade tensions and ...